Brief: Jacobson Pharma Posts H1 Net Income Attributable HK$140.3 Million
21/11/2024 10:51
Nov 21 (Reuters) - Jacobson Pharma Corporation H1 adjusted EBITDA HKD 272.2 million. * H1 revenue HKD 810 million * H1 net income attributable HKD 140.3 million
Recent news on Jacobson Pharma
See all newsBrief: Jacobson Pharma Corp Says Chai Herbal To Buy 124,500 Shares Of Li Chung Shing Tong (Holdings)
Brief: Jacobson Pharma Corp's Unit Accepts Tender For Tai Po Factory Works At Hk$607.2 Million
Brief: Jacobson Pharma Corp Posts H1 Revenue Of HKD 766.6 Million
Brief: Jacobson Pharma Corporation Posts FY Net Income Attributable HKD 300.8 Million
Brief: Jacobson Pharma Corporation To Subscribe Shares In Tycoon Group